FDA declares end to Wegovy and Ozempic shortage
The Future of Medication Access: Insights and Trends The recent end of the nationwide shortage of semaglutide, the key ingredient in popular diabetes and weight loss medications Ozempic and Wegovy, highlights significant shifts in the pharmaceutical industry. As companies invest heavily in manufacturing capacity, we explore what this means for the future of medication access. … Read more